newsfilter
← Latest News
GlobeNewswire·

Vigil Neuroscience to Present at Guggenheim 6th Annual Biotechnology Conference

WATERTOWN, Mass. , Feb. 07, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative